Cordis (Bridgewater, New Jersey), the stent making arm of Johnson & Johnson (J&J; New Brunswick, New Jersey), is pulling out of the drug-eluting stent (DES) business, as tougher competition and a flat market have eroded sales of these once top products. (Medical Device Daily) Read More
CerebralRx, a newly formed spin-off of BioControl Medical (both Yehud, Israel), is hitting the ground running with the launch of its FitNeS vagus nerve stimulation system for epilepsy in Europe.
(Medical Device Daily) Read More
